Name | hBChE-IN-1 |
---|
Description | hBChE-IN-1 (compound 4), a quinolizidinyl derivative, is a potent hBChE inhibitor (IC50=7 nM) and highly selective over hAChE. hBChE-IN-1 shows inhibitory activity against tau and Aβ40 protein aggregation, with IC50 values of 20 and 4.3 μM, respectively. hBChE-IN-1 can be used for Alzheimer's disease research[1]. |
---|---|
Related Catalog | |
Target |
hBCHE:0.0070 ± 0 μM (IC50) equine serum BChE:0.088 μM (IC50) EeAChE:0.18 μM (IC50) hAChE:7.84 ± 0.8 μM (IC50) |
References |
Molecular Formula | C27H34N2OS2 |
---|---|
Molecular Weight | 466.70 |